尿激酶静脉溶栓治疗脑梗死100例分析  

Clinical analysis of urokinase vein thrombolytic therapy for 100 patients with cerebral infarction

作　　者：凌天金[1] 

机构地区：[1]四川资阳市第一人民医院神经内科,资阳641300

出　　处：《中国实用神经疾病杂志》2013年第15期29-30,共2页Chinese Journal of Practical Nervous Diseases

摘　　要：目的探讨尿激酶及冰片注射液治疗脑梗死的疗效,为临床用药提供指导。方法将在我院接受治疗的100例急性脑梗死患者分为溶栓组和对照组各50例,溶栓组静脉滴注尿激酶进行治疗,对照组给予冰片注射液,根据患者恢复情况和临床神经功能缺损程度评分标准来评价药物疗效。结果溶栓组基本治愈率、显著进步率、总有效率分别为18%、30%、82%,对照组基本治愈率、显著进步率、总有效率分别为10%、22%、56%,2组比较差异均有统计学意义(P<0.05)。结论尿激酶静脉溶栓治疗脑梗死临床疗效显著,具有临床推广意义。Objective To discuss the effect difference between urokinase and borneol injection on cerebral infarction, and provide directions for clinical therapy. Methods One hundred cases of acute cerebral infarction patients in our hospital were randomly divided into the thrombolysis group and the control group and each group had 50 cases. The thrombolysis group was given with intravenous infusion of urokinase and the control group accepted intravenous infusion of borneol injection. The drug effect on stroke patients was evaluated by observing the recovery degree and clinical neurologic deficit score of patients. Results The basic cure rate, significant progress rate and total effective rate in the thrombolysis group were 18%, 30% and 82%, respectively. However, the basic cure rate, significant progress rate and total effective rate in the control group were 10%, 22M and 56%, respectively, which had a significant difference compared with the thrombolysis group. Conclusion Urokinase vein thrombolytic therapy had significantly clinical effect on patients with cerebral infarction.

关 键 词：脑梗死 尿激酶 冰片注射液 

分 类 号：R743.33[医药卫生—神经病学与精神病学]